The Therapeutic Goods Administration (TGA) is investigating a number of complaints alleging breaches of medicinal cannabis advertising rules.
The Therapeutic Goods Act states medicinal cannabis cannot be advertised direct to the public nor information published which promotes its use or supply. It is also illegal to reference serious medical conditions in advertising claiming a therapeutic benefit without prior approval by the TGA.
Those who break the rules could face criminal charges and/or civil penalties.
The TGA has sent cease-and-desist letters to the entities concerned and is prioritising complaints where it suspects consumers may be at risk because the products offered for sale have not been through regulatory checks.
While the majority have changed their advertising to comply with the law, the TGA says it is considering “appropriate actions” for those who haven’t.
For more information on TGA advertising rules, click here.